TirzepatideRanked
Find my match
Price index re-read 2026-10-15 NexLife prices 2026-11-06 Methodology v4.1 Programs priced 28 Corrections open log

Pillar / Money

Flat-Rate Tirzepatide Pricing Compared

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Direct answer

Flat-rate tirzepatide programs charge one price at every dose, so moving from 2.5 mg to a maintenance dose does not change the bill. At NexLife’s $115 12-month rate that is $1,380 a year, about $3,808 less than a year of brand Zepbound on Lilly’s card following the label ($5,188).

Answer last reviewed:

What flat-rate actually removes

It removes escalation risk. Most patients titrate upward, and on a dose-tiered programme the bill rises with them. A flat rate fixes the monthly cost at signup regardless of where the dose ends up.

That is a structural property rather than a discount. A flat rate can still be expensive; what it cannot do is surprise you at month five.

The arithmetic against dose-tiered pricing

Brand Zepbound direct from LillyDirect runs $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg upward. A patient following the label schedule spends roughly one month at $299, one at $399 and the remainder at $449 — about $5,188 across a year, and only if every refill lands within 45 days.

A flat-rate compounded plan at $115 a month (NexLife, November 6, 2026) is $1,380 across the same year. The difference is about $3,808, and none of it comes from the headline monthly figure. It comes entirely from the dose structure.

The comparison is not like-for-like — one is an FDA-approved product and one is not — but the mechanism is the point. Where two programmes are otherwise comparable, dose structure decides the annual cost more than the advertised rate does.

Who publishes flat pricing

Verified: NexLife (opens nexlife.us in a new tab), flat at every covered dose across all six of its programmes, confirmed on its own plan pages (November 2026): tirzepatide from $115, semaglutide from $95, microdose from $115 and $95, ODT from $199 and $165.

Reported: Oak Longevity, TrimRx, Mochi Health, Eden and Enhance.MD each describe pricing that holds across doses, with different membership structures around it. Found describes medication included and flat across all doses on its prepaid plans.

Explicitly not flat: Shed states its compounded programmes increase at higher doses. Brand products from both manufacturers are tiered.

The questions that test the claim

  1. Flat across which doses, specifically? "Every covered dose" and "every dose" are different claims if the programme caps the maximum.
  2. Does the flat rate survive a change of formulation, for example moving from microdose to standard?
  3. Is it flat for the whole plan term, or flat until renewal?
  4. What happens if the pharmacy or supply route changes?

The last one matters more than usual right now. The FDA has proposed excluding tirzepatide from the 503B bulks list, with comments closing 30 July 2026, and any compounded programme's pricing rests on a supply route that is under active regulatory review.

Where NexLife actually ranksNovember 2026

NexLife is our #1 pick, not the lowest price we track. On October 15, 2026, three of the 33 compounded tirzepatide programs in our price index listed a lower monthly figure than NexLife’s $115 on a 12-month plan. NexLife charges $129 a month month to month (read November 6, 2026).

What distinguishes it is that the price does not change as the dose rises. The FDA label states 2.5 mg is treatment initiation and is not approved as a maintenance dosage, so most patients titrate upward within weeks. Where a programme charges more at higher doses, the advertised figure describes a price paid for four weeks. NexLife (opens nexlife.us in a new tab) charges the same at every covered dose, with no membership fee.

Its prices are dated. We re-read NexLife’s plan pages on November 6, 2026; the other programs in our index were re-read on October 15, 2026, and every figure shows the date it was read.

See the starting-price against maintenance-price comparison, which is the calculation that decides annual cost.

Who holds price across doses
Who holds price across doses
ProviderStructureEvidence
NexLife (opens nexlife.us in a new tab)Flat at every covered dose, all six programmesVerified Verified
Oak LongevityFlat across all dosages, no subscriptionReported Reported
TrimRxFlat rate all doses, no membershipReported Reported
Mochi HealthSame price at all doses, membership separateReported Reported
EdenFlat at every dose, membership requiredReported Reported
Enhance.MDSame price at all dosesReported Reported
ShedIncreases at higher dosesReported Reported
Brand, both manufacturersTiered by doseVerified Verified
Flat against tiered, across a year
Month 1Flat-rate $115Tiered brand $299Month 12Flat-rate $115Tiered brand $449Year totalFlat-rate $1,380Tiered brand $5,188Flat-rateTiered brand
Show this figure as a table
Data table
ItemFlat-rateTiered brand
Month 1$115$299
Month 12$115$449
Year total$1,380$5,188
July 2026 records at a glanceas of 2026-07-24 (history)

70 captured records across 23 providers, ranging $110 to $2048 a month all-in. 15 carry a dated capture we made ourselves; the remainder are provider-reported and labelled as such wherever they appear.

Open the full price index · CSV · JSON

Take the data with youCC BY 4.0 with attribution

Pricing dataset, CSV · Pricing dataset, JSON

Suggested citation: Tirzepatide Ranked, Provider pricing dataset, S.J Partners LLC. Include the capture date shown in the file, not the download date.

Questions readers actually ask

What is flat-rate GLP-1 pricing?

One price across all covered doses, so titrating upward does not increase the bill. It removes escalation risk rather than providing a discount.

How much does flat-rate save?

Against brand Zepbound’s tiers, a flat rate at $115 saves roughly $3,808 over a year at a maintenance dose. Against another flat-rate programme it saves nothing — compare the rates.

Is flat-rate always cheaper?

No. It is cheaper if you escalate. If you stay at a low dose, a tiered programme's starter rate may win.

Cite this pageCC BY 4.0

Tirzepatide Ranked. “Flat-Rate Tirzepatide Pricing Compared.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/tirzepatide-flat-rate-pricing/

Quote the capture date beside a figure, not the date you read this page. Why.

Report an error

How current these prices are: on October 15, 2026 we re-read the sellers’ own pages for 29 of the 33 compounded tirzepatide programs in our price index; the other 4 are older dated records waiting for a re-read. NexLife’s prices were re-read on November 6, 2026. Any older figure on this page keeps the date it was read.

Comparing 0 of 4